Prevalence of Erectile Dysfunction in Patients with Diabetes Mellitus and Its Association with Body Mass Index and Glycated Hemoglobin in Africa: A Systematic Review and Meta-Analysis.
Journal
International journal of endocrinology
ISSN: 1687-8337
Titre abrégé: Int J Endocrinol
Pays: Egypt
ID NLM: 101516376
Informations de publication
Date de publication:
2020
2020
Historique:
received:
12
11
2019
revised:
16
12
2019
accepted:
30
12
2019
entrez:
16
5
2020
pubmed:
16
5
2020
medline:
16
5
2020
Statut:
epublish
Résumé
Mortality and morbidity in patients with diabetes mellitus (DM) are attributed to both microvascular and macrovascular complications. However, there is a significant amount of variation in the primary studies on DM regarding the prevalence of erectile dysfunction (ED) in Africa. Therefore, this study was aimed to estimate the pooled prevalence of ED patients with DM and its association with body mass index (BMI) and glycated hemoglobin in Africa. PubMed, Web of Science, Cochrane Library, Scopus, PsycINFO, African Journals Online, and Google Scholar were searched for studies that looked at ED in DM patients. A funnel plot and Egger's regression test were used to determine publication bias. The A total of 13 studies with 3,501 study participants were included in this study. We estimated that the pooled prevalence of ED in patients with DM in Africa was 71.45% (95% CI: 60.22-82.69). Diabetic patients whose BMI was ≥30 kg/m The prevalence of ED in DM patients in Africa remains high. Therefore, situation-based interventions and country context-specific preventive strategies should be developed to reduce the prevalence of ED among patients with DM.
Sections du résumé
BACKGROUND
BACKGROUND
Mortality and morbidity in patients with diabetes mellitus (DM) are attributed to both microvascular and macrovascular complications. However, there is a significant amount of variation in the primary studies on DM regarding the prevalence of erectile dysfunction (ED) in Africa. Therefore, this study was aimed to estimate the pooled prevalence of ED patients with DM and its association with body mass index (BMI) and glycated hemoglobin in Africa.
METHODS
METHODS
PubMed, Web of Science, Cochrane Library, Scopus, PsycINFO, African Journals Online, and Google Scholar were searched for studies that looked at ED in DM patients. A funnel plot and Egger's regression test were used to determine publication bias. The
RESULT
RESULTS
A total of 13 studies with 3,501 study participants were included in this study. We estimated that the pooled prevalence of ED in patients with DM in Africa was 71.45% (95% CI: 60.22-82.69). Diabetic patients whose BMI was ≥30 kg/m
CONCLUSIONS
CONCLUSIONS
The prevalence of ED in DM patients in Africa remains high. Therefore, situation-based interventions and country context-specific preventive strategies should be developed to reduce the prevalence of ED among patients with DM.
Identifiants
pubmed: 32411224
doi: 10.1155/2020/5148370
pmc: PMC7201640
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
5148370Informations de copyright
Copyright © 2020 Wondimeneh Shibabaw Shiferaw et al.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
Reprod Biol Endocrinol. 2011 May 25;9:70
pubmed: 21612653
BJU Int. 2007 Jan;99(1):130-4
pubmed: 17026597
N Engl J Med. 1989 Apr 20;320(16):1025-30
pubmed: 2927481
Ann Afr Med. 2018 Oct-Dec;17(4):215-220
pubmed: 30588936
Int J Impot Res. 2010 Sep-Oct;22(5):310-7
pubmed: 20811390
Diabetes Care. 2002 Aug;25(8):1458-63
pubmed: 12145250
PLoS One. 2018 Sep 10;13(9):e0202413
pubmed: 30199531
Diabetes. 1974 Apr;23(4):306-9
pubmed: 4823910
Psychol Methods. 2006 Jun;11(2):193-206
pubmed: 16784338
Diabetes Care. 1998 Nov;21(11):1973-7
pubmed: 9802753
Sao Paulo Med J. 2002 Mar 7;120(2):49-54
pubmed: 11994773
JAMA. 1993 Jul 7;270(1):83-90
pubmed: 8510302
Prim Care Diabetes. 2015 Apr;9(2):147-54
pubmed: 24933340
J Urol. 2003 Mar;169(3):1043-7
pubmed: 12576842
J Sex Med. 2009 May;6(5):1232-47
pubmed: 19210706
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Ann Endocrinol (Paris). 2006 Sep;67(4):338-42
pubmed: 17072239
JAMA. 2004 Jun 23;291(24):2978-84
pubmed: 15213209
J Sex Med. 2015 Jun;12(6):1309-18
pubmed: 25872648
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
N Engl J Med. 2000 Jun 15;342(24):1802-13
pubmed: 10853004
Clin Med Insights Endocrinol Diabetes. 2015 Jul 19;8:55-62
pubmed: 26244038
J Cardiovasc Risk. 2003 Apr;10(2):97-102
pubmed: 12668906
Diabet Med. 2017 Sep;34(9):1185-1192
pubmed: 28722225
BMC Endocr Disord. 2017 Mar 15;17(1):16
pubmed: 28298205
Int J Impot Res. 2003 Aug;15(4):237-45
pubmed: 12934050
Eur Urol. 2001 Oct;40(4):392-6; discussion 397
pubmed: 11713392
BMC Res Notes. 2018 Feb 15;11(1):130
pubmed: 29448969
J Sex Med. 2010 Apr;7(4 Pt 2):1627-56
pubmed: 20388162
BJU Int. 1999 Jul;84(1):50-6
pubmed: 10444124
PLoS One. 2016 Jan 25;11(1):e0147601
pubmed: 26808317
Int J Impot Res. 2003 Apr;15 Suppl 1:S3-7
pubmed: 12825102
Diabetes Care. 2005 Nov;28(11):2637-43
pubmed: 16249532
Pan Afr Med J. 2014 Mar 26;17:227
pubmed: 25170371
Diabet Med. 2006 Feb;23(2):198-203
pubmed: 16433719
J Urol. 2001 Nov;166(5):1624-32
pubmed: 11586190
Asian J Psychiatr. 2014 Feb;7(1):58-65
pubmed: 24524711
Niger Postgrad Med J. 2006 Dec;13(4):291-6
pubmed: 17203117
Endocrine. 2004 Mar-Apr;23(2-3):119-23
pubmed: 15146089